Brave Little World: Spheroids as an in vitro Model to Study Tumor-Immune-Cell Interactions

Multicellular tumor spheroids (MCTS) are a well established 3-D in vitro model system that reflects the pathophysiological in vivo situation in tumor microregions and of avascular micrometastatic sites. Because monocytes and other immune cells infiltrate into MCTS of different origin, such spheroid co-cultures are a valuable, still underestimated tool to systematically study heterologous interactions between tumor and immune cells. The present article gives a brief overview on work that has been published on tumor - immune cell interactions in MCTS and also summarizes mechanisms of immune suppression in the tumor milieu focussing on myeloid cells. Using the co-culture model, we recently demonstrated that tumor-derived lactic acid is a potent modulator of human monocyte as lactic acid inhibited the differentiation of monocytes (MO) into dendritic cells (DC) and also impaired antigen presentation. We show herein, that the capacity of various tumor cells in MCTS to secrete lactic acid differs up to tenfold, suggesting that this capacity is dependent on the tumor cell type. It is further demonstrated that lactic acid disturbs the migration of MO into MCTS as infiltration could be increased by blocking lactic acid production. We therefore discuss lactic acid which accumulates in many tumors and tumor microregions as a potent immune suppressor for MO/DC in the tumor milieu and conclude that these data are highly relevant for adoptive immunotherapy protocols with DC.

[1]  K. Papas,et al.  Change in lactate production in Myc‐transformed cells precedes apoptosis and can be inhibited by Bcl‐2 overexpression , 1999, FEBS letters.

[2]  R. Audran,et al.  Interactions between human macrophages and tumor cells in three-dimensional cultures , 1994, Cancer Immunology, Immunotherapy.

[3]  J. M. Arbeit,et al.  Coordinate up-regulation of hypoxia inducible factor (HIF)-1alpha and HIF-1 target genes during multi-stage epidermal carcinogenesis and wound healing. , 2000, Cancer research.

[4]  A. Harris,et al.  Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.

[5]  H. Lyng,et al.  Correlation of high lactate levels in head and neck tumors with incidence of metastasis. , 1997, The American journal of pathology.

[6]  J. Abbruzzese,et al.  Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells , 2001, Oncogene.

[7]  J. Blay,et al.  IL-4 prevents the blockade of dendritic cell differentiation induced by tumor cells. , 2001, Cancer research.

[8]  P. Allavena,et al.  Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. , 2004, European journal of cancer.

[9]  B. Ebert,et al.  Isoenzyme-specific regulation of genes involved in energy metabolism by hypoxia: similarities with the regulation of erythropoietin. , 1996, The Biochemical journal.

[10]  A. Mui,et al.  SHIP represses the generation of alternatively activated macrophages. , 2005, Immunity.

[11]  S. Koyasu,et al.  IFN‐γ and pro‐inflammatory cytokine production by antigen‐presenting cells is dictated by intracellular thiol redox status regulated by oxygen tension , 2002, European journal of immunology.

[12]  H. Bitterman,et al.  Hypoxia reduces CD80 expression on monocytes but enhances their LPS-stimulated TNF-alpha secretion. , 2003, Journal of leukocyte biology.

[13]  J. Morton,et al.  CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer , 2003, British Journal of Cancer.

[14]  A. Lardner The effects of extracellular pH on immune function , 2001, Journal of leukocyte biology.

[15]  R. Andreesen,et al.  Three‐dimensional co‐culture of human monocytes and macrophages with tumor cells: Analysis of macrophage differentiation and activation , 1996, International journal of cancer.

[16]  F. Mullick,et al.  Presence and Localization of Three Lactic Acid Transporters (MCT1, −2, and −4) in Separated Human Granulocytes, Lymphocytes, and Monocytes , 2004, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[17]  R. Sutherland Cell and environment interactions in tumor microregions: the multicell spheroid model. , 1988, Science.

[18]  W. Kaelin,et al.  Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[20]  A. Puig-Kröger,et al.  Peritoneal dialysis solutions inhibit the differentiation and maturation of human monocyte‐derived dendritic cells: effect of lactate and glucose‐degradation products , 2003, Journal of leukocyte biology.

[21]  D. Carbone,et al.  Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-kappa B activation in hemopoietic progenitor cells. , 1998, Journal of immunology.

[22]  F. Balkwill,et al.  Inhibition of monocyte and macrophage chemotaxis by hypoxia and inflammation – a potential mechanism , 2001, European journal of immunology.

[23]  A. Enk,et al.  Dendritic cells as mediators of tumor‐induced tolerance in metastatic melanoma , 1997, International journal of cancer.

[24]  R. Knuechel,et al.  Tumor‐associated fibroblasts recruit blood monocytes into tumor tissue , 2003, European journal of immunology.

[25]  W. Frankel,et al.  Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles , 2004, Oncogene.

[26]  S. Tsujitani,et al.  Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue. , 1998, British Journal of Cancer.

[27]  M. Mori,et al.  S‐100 protein‐positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis , 1989, Cancer.

[28]  Dirk Schadendorf,et al.  Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells , 1998, Nature Medicine.

[29]  S. Dubinett,et al.  Tumors Promote Altered Maturation and Early Apoptosis of Monocyte-Derived Dendritic Cells1 , 2000, The Journal of Immunology.

[30]  Y. Maehara,et al.  Lymph node metastasis and relation to tumor growth potential and local immune response in advanced gastric cancer. , 1997, International journal of cancer.

[31]  R K Jain,et al.  Hypoxia and acidosis independently up-regulate vascular endothelial growth factor transcription in brain tumors in vivo. , 2001, Cancer research.

[32]  A. Paetau,et al.  Effect of LAK cells against three-dimensional tumor tissue. In vitro study using multi-cellular human glioma spheroids as targets. , 1989, Journal of immunology.

[33]  L. Kunz-Schughart,et al.  The fibroblast: Sentinel cell and local immune modulator in tumor tissue , 2004, International journal of cancer.

[34]  M. Merad,et al.  Induction of potent antitumor immunity by in situ targeting of intratumoral DCs. , 2004, The Journal of clinical investigation.

[35]  R. Jove,et al.  Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer , 2004, The Journal of Immunology.

[36]  R. Andreesen,et al.  Identification of genes expressed in tumor-associated macrophages. , 2003, Immunobiology.

[37]  K. O'Byrne,et al.  Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[38]  D. Hart,et al.  Review: Dendritic Cells and Cancer: Progress Toward a New Cellular Therapy , 1997 .

[39]  T. Schroeder,et al.  Lactate in solid malignant tumors: potential basis of a metabolic classification in clinical oncology. , 2004, Current medicinal chemistry.

[40]  H. Klocker,et al.  Human renal‐cell carcinoma tissue contains dendritic cells , 1996, International journal of cancer.

[41]  A. Sica,et al.  A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). , 2006, Blood.

[42]  M. Goldman,et al.  Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cells , 1995, European journal of immunology.

[43]  D. Carbone,et al.  Clinical significance of defective dendritic cell differentiation in cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[44]  A. Mackensen,et al.  Tumor-derived lactic acid modulates dendritic cell activation and antigen expression. , 2006, Blood.

[45]  D. Carbone,et al.  Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors. , 1998, Journal of immunology.

[46]  L. Kunz-Schughart,et al.  Multicellular tumor spheroids: intermediates between monolayer culture and in vivo tumor , 1999, Cell biology international.

[47]  C. Lewis,et al.  Hypoxia-induced gene expression in human macrophages: implications for ischemic tissues and hypoxia-regulated gene therapy. , 2003, The American journal of pathology.

[48]  A. Harris,et al.  The expression and distribution of the hypoxia-inducible factors HIF-1alpha and HIF-2alpha in normal human tissues, cancers, and tumor-associated macrophages. , 2000, The American journal of pathology.

[49]  J. Banchereau,et al.  In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, Whereas Mature Dendritic Cells Are Located in Peritumoral Areas , 1999, The Journal of experimental medicine.

[50]  P. Hahnfeldt,et al.  Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. , 1994, Cancer research.

[51]  O. Warburg [On the facultative anaerobiosis of cancer cells and its use in chemotherapy]. , 1961, Munchener medizinische Wochenschrift.

[52]  R. Foà,et al.  The circulating dendritic cell compartment in patients with chronic lymphocytic leukemia is severely defective and unable to stimulate an effective T-cell response. , 2003, Cancer research.

[53]  Hua Yu,et al.  Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells , 2004, Nature Medicine.

[54]  Stefan Walenta,et al.  Lactate: mirror and motor of tumor malignancy. , 2004, Seminars in radiation oncology.

[55]  Huasheng Lu,et al.  Hypoxia-inducible Factor 1 Activation by Aerobic Glycolysis Implicates the Warburg Effect in Carcinogenesis* , 2002, The Journal of Biological Chemistry.

[56]  R. Andreesen,et al.  Cytokine repertoire during maturation of monocytes to macrophages within spheroids of malignant and non‐malignant urothelial cell lines , 1998, International journal of cancer.

[57]  D. Carbone,et al.  Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells , 1996, Nature Medicine.

[58]  Ugur Sahin,et al.  Human Cancer , 2006 .

[59]  S. Hauptmann,et al.  Macrophages and multicellular tumor spheroids in co-culture: a three-dimensional model to study tumor-host interactions. Evidence for macrophage-mediated tumor cell proliferation and migration. , 1993, American Journal of Pathology.

[60]  T. Ogata,et al.  Immunohistochemical analysis of dendritic/Langerhans cells in thyroid carcinomas. , 1995, Analytical Cellular Pathology.

[61]  D. Gabrilovich,et al.  STAT1 Signaling Regulates Tumor-Associated Macrophage-Mediated T Cell Deletion1 , 2005, The Journal of Immunology.

[62]  Yi-Chen Lin,et al.  Tumor-associated macrophages: the double-edged sword in cancer progression. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[63]  R. Knuechel,et al.  Multicellular spheroids: a three‐dimensional in vitro culture system to study tumour biology , 1998, International journal of experimental pathology.

[64]  J. Faivre,et al.  Inflammatory cells infiltrating human colorectal carcinomas express HLA class II but not B7-1 and B7-2 costimulatory molecules of the T-cell activation. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[65]  C. Scotton,et al.  Hypoxia inhibits macrophage migration , 1999, European journal of immunology.

[66]  D. Carbone,et al.  Differential Roles of Vascular Endothelial Growth Factor Receptors 1 and 2 in Dendritic Cell Differentiation1 , 2005, The Journal of Immunology.

[67]  J. Blay,et al.  Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. , 1998, Blood.

[68]  James P. Freyer,et al.  The Use of 3-D Cultures for High-Throughput Screening: The Multicellular Spheroid Model , 2004, Journal of biomolecular screening.

[69]  N. Price,et al.  The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. , 1999, The Biochemical journal.

[70]  Naiem A. Zeid,et al.  S 100 Positive Dendritic Cells In Human Lung Tumors Associated With Cell Differentiation And Enhanced Survival , 1993, Pathology.

[71]  F. Balkwill,et al.  Hypoxia down‐regulates MCP‐1 expression: implications for macrophage distribution in tumors , 1998, Journal of leukocyte biology.

[72]  E. Rofstad,et al.  High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers. , 2000, Cancer research.